Navigation Links
Another JDRF partner moves research forward with collaboration agreement for diabetes treatment
Date:6/18/2009

NEW YORK, June 18, 2009 The Juvenile Diabetes Research Foundation said today that for the fourth time in 18 months, one of its biotech partners has signed a collaboration agreement with a large pharmaceutical company to move research on type 1 diabetes into the final phases of trials.

According to JDRF, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 diabetes research, the development is the latest success in its innovative Industry Discovery and Development Partnership (IDDP) program, through which JDRF provides early stage research funding to biotech companies working on technologies and therapeutic candidates.

In the most recent success, JDRF industry partner Bayhill Therapeutics Inc., based in California, entered into a collaboration agreement with Genentech, Inc., a wholly owned member of the Roche Group, to further develop and potentially commercialize a novel antigen-specific immunotherapeutic designed to reverse the immune response that causes type 1 diabetes.

To date, JDRF has awarded more than $29 million in research funding to 25 companies through its IDDP program. JDRF supported the ongoing Bayhill clinical trial with an IDDP grant in October of 2008.

"We began the IDDP program to help small companies demonstrate proof-of-principle for innovative ideas and products to treat and cure type 1 diabetes, in order to attract funding for potential commercialization from large drug companies," said Alan J. Lewis, PhD, President and Chief Executive Officer of JDRF. "This latest agreement further demonstrates that the strategy is successful in accelerating the pace of research leading to a cure for diabetes."

Dr. Lewis noted that the development underscores JDRF's unique role helping to accelerate and translate research discoveries into cures and better treatment of type 1 diabetes and its complications. By supporting early stage rese
'/>"/>

Contact: William Ahearn
wahearn@jdrf.org
212-479-7531
Juvenile Diabetes Research Foundation International
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. One species entire genome discovered inside anothers
2. Same gene protects from 1 disease, opens door to another
3. Another type of nanotube, a how-to guide to making bamboo-structured carbon nanotubes
4. For good or ill Ireland gains another mammal species
5. Ocean acidification -- another undesired side effect of fossil fuel-burning
6. Viral recombination another way HIV fools the immune system
7. Arctic ice on the verge of another all-time low
8. Another fisheries commission throws the science overboard in tuna decision, WWF says
9. Another reason to drink a nice cup of shade-grown joe
10. Cancer: Another step towards medication
11. Desert woodrats switch one dietary poison for another

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...entists at the California Institute of Technology ...motion-like behavior in the fruit fly, Drosophila...elevant to the relationship between the neurotrans...y disorder (ADHD), are described in the December i... brain contains only about 20,000 neurons and has ...
(Date:11/25/2009)..., Head of the Cell Death Research Laboratory in th... been awarded the prestigious Johnson & Johnson Fo... cause of brain cell damage in Parkinson,s disease...sts in support of innovation and excellence in sci...red earlier this month at an event at the Hyatt Re...
(Date:11/25/2009)...you eat may be just as vital to your health as wha... for Biological Studies. Their experiments in mice...sands of genes in the liverthe body,s metabolic cl... not by the body,s circadian clock as conventional...he activity of a large number of genes completely ...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Feeding the clock 2Feeding the clock 3FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 1FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 2FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 3Leading Trauma Surgeon Paints a Bleak Picture of U S Trauma System Calls for Surgeons to Advocate for Systems Where Lacking 5444 1Leading Trauma Surgeon Paints a Bleak Picture of U S Trauma System Calls for Surgeons to Advocate for Systems Where Lacking 5444 2Leading Trauma Surgeon Paints a Bleak Picture of U S Trauma System Calls for Surgeons to Advocate for Systems Where Lacking 5444 3CareFusion Launches 10 Pound High Performance Critical Care Ventilator in the U S 10347 1CareFusion Launches 10 Pound High Performance Critical Care Ventilator in the U S 10347 2CareFusion Launches 10 Pound High Performance Critical Care Ventilator in the U S 10347 3
...tional Children,s Mental Health Awareness Day on T... Study of Violence Against Children (CSVAC) will h...om Neuroscience to Social Practice: Translational ...y event, being held May 7-8 in Lexington, Ky., inc...ce against children that will be published in an u...
... vulnerable to their environment during embryonic ...nova and Ruedi Nager from the University of Glasgo...elopmental rate and susceptibility to unfavorable ...e received little attention. The paper (1) has jus...Ecology and Sociobiology. , In many birds, siblin...
...ffort in Support of "New Employee,Verification Act...sociation devoted to human resource management tod...essionals to endorse the "New Employee,Verificatio...nd Means,Subcommittee on Social Security, Sue Meis... to recognize that the current employment verifica...
Other Biology News:National scientific meeting on child mental health at Kentucky 2National scientific meeting on child mental health at Kentucky 3Seagulls: Are males the weaker sex? 2SHRM CEO Testifies Before House Subcommittee on Social Security 2SHRM CEO Testifies Before House Subcommittee on Social Security 3
(Date:11/24/2009)...swire/ -- Blue Marble Energy Corp. announced today...t Authority (OPDA) were recently awarded $2 millio...ization Board (CERB) in a private/public partnersh...mical biorefinery in Lincoln County, WA. ,, "...opment of our biorefinery and bring over 70 green ...
(Date:11/24/2009)...endpoint has been met for patients with advanced-s...UEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEter...Company"), a global biopharmaceutical company focu...nced positive efficacy data from a Phase 2 study w...-108 (formerly AN-152), in patients with advanced ...
(Date:11/24/2009)...4 Shire plc (LSE: SHP,N...tical company, today,announced that it has submitt...glucerase alfa, the company,s enzyme replacement t...Gaucher disease. This is the third marketing,appli...ted, with previous,submissions in the United State...
(Date:11/24/2009)... Nov. 24 Genomic Health,...Scott, Genomic Health,s Executive Chairman, will p...e Conference in New York City on Tuesday, December...ve and subsequently archived webcast of the presen...nomic Health,s website at http://investor.genomic...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
... GE Healthcare will provide digital imaging system...c health-care initiative, the company announced on... to install systems nationwide to allow medical im...erts can look at them on demand. It will spend abo...ued around $200 million. , ,GE Healthcare is based...
...angry Mediterranean Sea roaring at my back, pausin...eli start-ups as the first winter storm hits Tel A...Europe and Israel, taking an assessment of the tec...ng to DEMO@15 in February. , ,What strikes me on t... European technology ventures is rapidly closing. ...
...government, business and academia are worried. The...ecedented level. Most economists including Federal...n opposite sides of the political spectrum are con... term for our government to spend far more than it...our international trade imbalance. The United Stat...
Other Biology Technology:Innovation thrives in Europe 2Innovation thrives in Europe 3Corporate Americas hidden deficit 2Corporate Americas hidden deficit 3
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-DM 2 x 109 cells from BD Biosciences Pharmingen
Rabbit Anti-Staphylococcus Enterotoxin E Polyclonal Antibody, Biotin Conjugated from Abcam
...i is an endoribonuclease that specifically digests...at have 2-base, 3'-overhangs. Complete digestion ...RNase III can digest double-stranded RNA composed ...™ RNA, produced using EPICENTRE's DuraScribe&...
arrayWoRxe from Applied Precision, LLC
Biology Products: